Drug-free Without Toothache. A Study of Free Dental Treatment as a Part of Substance Abuse Treatment
Launched by UNIVERSITY HOSPITAL OF NORTH NORWAY · Oct 31, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Drug-free Without Toothache," is exploring how offering free dental care during substance abuse treatment affects patients. The researchers want to find out how many patients will take advantage of the free dental treatment while staying at the University Hospital North Norway in Narvik. They are also looking to see if getting dental care at the same time as drug treatment helps or hinders the overall recovery process.
To participate in this study, individuals must be hospitalized for drug abuse at the Russeksjon unit in Narvik, and there are no specific exclusions based on other health conditions. If someone joins the trial, they can expect to receive dental care at no cost while undergoing their substance abuse treatment. This study is currently recruiting participants, aiming to understand the relationship between dental health and recovery from substance abuse.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • People who are hospitalized for drug abuse at Russeksjon UNN Narvik.
- Exclusion Criteria:
- • Non
About University Hospital Of North Norway
The University Hospital of North Norway (UNN) is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. As a key institution within the Norwegian health system, UNN combines cutting-edge medical practice with rigorous scientific inquiry, fostering collaboration among healthcare professionals, researchers, and academic partners. The hospital is committed to improving patient outcomes and enhancing the understanding of various health conditions through its extensive portfolio of clinical studies, which span multiple disciplines and focus on translating research findings into effective treatments and care strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Narvik, Nordland, Norway
Patients applied
Trial Officials
Merethe Kumle, MD, PhD
Principal Investigator
University Hospital of North Norway
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials